Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashkan Emadi

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
Acta Haematologica|January 30, 2019
Relapsed Philadelphia Chromosome-Positive Pre-B-ALL after CD19-Directed CAR-T Cell Therapy Successfully Treated with Combination of Blinatumomab and PonatinibFiras El Chaer, Noa G Holtzman, Edward A Sausville, et al.
British Journal of Haematology|December 6, 2019
Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemiaNoa G Holtzman, Firas El Chaer, Maria R Baer, et al.
Biology|June 24, 2022
Impact of <i>FLT3</i>-ITD Insertion Length on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort StudyElizabeth M Corley, Moaath K Mustafa Ali, Hanan Alharthy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2022
Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid LeukemiaMaria R Baer, Aksinija A Kogan, Søren M Bentzen, et al.
International Journal of Epidemiology|April 10, 2013
A U-shaped relationship between haematocrit and mortality in a large prospective cohort studyPaolo Boffetta, Farhad Islami, Rajesh Vedanthan, et al.
Blood Advances|February 9, 2021
Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclaxBlake S Moses, Samantha McCullough, Jennifer M Fox, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 29, 2019
Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and managementNajeebah A Bade, Crystal Lu, Ciera L Patzke, et al.
American Journal of Hematology|May 24, 2019
Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumabSrilakshmi Bathini, Noa G Holtzman, Rima Koka, et al.
American Journal of Hematology|October 18, 2018
Treatment of CD19-positive mixed phenotype acute leukemia with blinatumomabFiras El Chaer, Omer M Ali, Edward A Sausville, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 17, 2021
Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemiaKyle Zacholski, Bryan Hambley, Erin Hickey, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Acta Haematologica|January 30, 2019
Relapsed Philadelphia Chromosome-Positive Pre-B-ALL after CD19-Directed CAR-T Cell Therapy Successfully Treated with Combination of Blinatumomab and PonatinibFiras El Chaer, Noa G Holtzman, Edward A Sausville, et al.
British Journal of Haematology|December 6, 2019
Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemiaNoa G Holtzman, Firas El Chaer, Maria R Baer, et al.
Biology|June 24, 2022
Impact of <i>FLT3</i>-ITD Insertion Length on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort StudyElizabeth M Corley, Moaath K Mustafa Ali, Hanan Alharthy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2022
Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid LeukemiaMaria R Baer, Aksinija A Kogan, Søren M Bentzen, et al.
International Journal of Epidemiology|April 10, 2013
A U-shaped relationship between haematocrit and mortality in a large prospective cohort studyPaolo Boffetta, Farhad Islami, Rajesh Vedanthan, et al.
Blood Advances|February 9, 2021
Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclaxBlake S Moses, Samantha McCullough, Jennifer M Fox, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 29, 2019
Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and managementNajeebah A Bade, Crystal Lu, Ciera L Patzke, et al.
American Journal of Hematology|May 24, 2019
Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumabSrilakshmi Bathini, Noa G Holtzman, Rima Koka, et al.
American Journal of Hematology|October 18, 2018
Treatment of CD19-positive mixed phenotype acute leukemia with blinatumomabFiras El Chaer, Omer M Ali, Edward A Sausville, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 17, 2021
Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemiaKyle Zacholski, Bryan Hambley, Erin Hickey, et al.
Pageof 12